September 27, 2011
With the venture capital market cooling this year, the cash that is available continues to line up behind some of the more high profile Web-based companies, which could spell disaster for technology development in our once high-flying biotech and medical fields. Medical and biotech companies rely heavily on venture capital funding, but the flow of […]
Read the full article →
September 23, 2011
This year has seen much more than the normal tumult in the markets and the impact on venture investment has raised the prospect of yet another period of under-performance in the venture capital industry. Despite venture capital investment in the U.S. attaining a three-year high through the second quarter, the increasing market volatility and steep […]
Read the full article →